Is Next Generation Sequencing (NGS) Ready for Routine Clinical Practice in Gliomas? Results of a Prospective Study Utilizing the MSK-IMPACT Assay
Omuro A, Zehir A, Cheng D, Berger M, Hyman D, Solit D, Baselga J, Ladanyi M, Arcila M, Hameed M, Sabbatini P, DeAngelis L, Gutin P, Rosenblum M, Mellinghoff I, Tabar V, Chan T, Briggs S, Huse J, Brennan C. Is Next Generation Sequencing (NGS) Ready for Routine Clinical Practice in Gliomas? Results of a Prospective Study Utilizing the MSK-IMPACT Assay. Journal Of Clinical Oncology 2015, 33: 2057-2057. DOI: 10.1200/jco.2015.33.15_suppl.2057.Peer-Reviewed Original ResearchNext-generation sequencingRoutine clinical practiceProspective studyMSK-IMPACTClinical practiceGeneration sequencingGliomas